Model Continuums of Care Initiative (MCCI) for Women and Girls at Risk and Living With HIV/AIDS and Harmful Alcohol and Associated Comorbidities Planning Cooperative Agreement (U34)
The summary for the Model Continuums of Care Initiative (MCCI) for Women and Girls at Risk and Living With HIV/AIDS and Harmful Alcohol and Associated Comorbidities Planning Cooperative Agreement (U34) grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact.
If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Model Continuums of Care Initiative (MCCI) for Women and Girls at Risk and Living With HIV/AIDS and Harmful Alcohol and Associated Comorbidities Planning Cooperative Agreement (U34): The purpose of the Model Continuums of Care Initiative (MCCI) for Women and Girls at Risk and Living with HIV/AIDS and Harmful Alcohol and Associated Comorbidities Initiative is to promote the development and evaluation of integrated multilevel interventions to reduce alcohol consumption as a key approach to preventing new infections and enhancing treatment adherence in communities in the U.S. where racial and ethnic minority women bear a disproportionate share of the HIV/AIDS disease burden. Using the U34 Planning Cooperative Agreement mechanism and a community-based participatory research approach, MCCI will support implementation and operations research to: 1) Improve screening and early engagement in care; 2) Enhance retention in care; 3) Improve medication adherence; and 4) Address the role of alcohol in the adoption of female-controlled HIV prevention strategies as they become available for implementation (i.e., microbicides, PrEP). Results of this research will provide the evidence base for the development of more effective systems of care for women and girls at risk and living with HIV, including pregnant mothers who engage in risky drinking and other substance use.
Federal Grant Title: | Model Continuums of Care Initiative (MCCI) for Women and Girls at Risk and Living With HIV/AIDS and Harmful Alcohol and Associated Comorbidities Planning Cooperative Agreement (U34) |
Federal Agency Name: | National Institutes of Health (HHS-NIH11) |
Grant Categories: | Health |
Type of Opportunity: | Discretionary |
Funding Opportunity Number: | RFA-AA-17-013 |
Type of Funding: | Cooperative Agreement |
CFDA Numbers: | 93.273 |
CFDA Descriptions: | Information not provided |
Current Application Deadline: | December 2nd, 2016 |
Original Application Deadline: | December 2nd, 2016 |
Posted Date: | September 23rd, 2016 |
Creation Date: | September 23rd, 2016 |
Archive Date: | January 2nd, 2017 |
Total Program Funding: | |
Maximum Federal Grant Award: | $225,000 |
Minimum Federal Grant Award: | |
Expected Number of Awards: | |
Cost Sharing or Matching: | No |
Last Updated: | September 23rd, 2016 |
- Applicants Eligible for this Grant
- State governments - County governments - City or township governments - Special district governments - Independent school districts - Public and State controlled institutions of higher education - Native American tribal governments (Federally recognized) - Public housing authorities/Indian housing authorities - Native American tribal organizations (other than Federally recognized tribal governments) - Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education - Private institutions of higher education - For-profit organizations other than small businesses - Small businesses - Others (see text field entitled "Additional Information on Eligibility" for clarification.)
- Additional Information on Eligibility
- Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.
- Link to Full Grant Announcement
- http://grants.nih.gov/grants/guide/rfa-files/RFA-AA-17-013.html
- Grant Announcement Contact
- NIH OER Webmaster
[email protected]
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster - Similar Government Grants
- • Independent Scientist Award (Parent K02 Independent Basic Experimental Studies with Humans...
- • Independent Scientist Award (Parent K02 - Independent Clinical Trial Required)
- • Limited Competition: Alcohol-associated Hepatitis Clinical Network Integrated Treatment C...
- • Limited Competition: Alcohol-associated Hepatitis Clinical Network Integrated Treatment C...
- • Model Continuums of Care Initiative (MCCI) to Advance Health Equity and End Health Dispari...
- • Mechanisms of Alcoholic Pancreatitis
- • Alcohol Abuse and Hiv/Aids in Resource-Poor Societies
- • Mechanisms of Alcohol-Induced Tissue Injury
- More Grants from the National Institutes of Health
- • Advancing HIV service delivery through pharmacies and pharmacists (R21 Clinical Trial Opti...
- • Advancing HIV service delivery through pharmacies and pharmacists (R01 Clinical Trial Opti...
- • Small Business Transition Grant for New Entrepreneurs (R43/R44 Clinical Trial Required)
- • Independent Scientist Award (Parent K02 Independent Basic Experimental Studies with Humans...
- • Coordinating Center for Type 1 Diabetes TrialNet (U01 Clinical Trial Required)